Clinical and hematologic presentations of adults with COVID-19 patients in Jeddah: A case control study

Fatemah O Kamel1, Rania M Magadmi1, Sulafa T Alqutub2

  • 1Pharmacology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Insights

Male gender, hypertension, and diabetes are key risk factors for COVID-19 (Coronavirus disease 2019). This study in Jeddah identified lower lymphocyte and neutrophil counts in patients with SARS-CoV-2 infection.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents significant morbidity and mortality.
  • While clinical features are documented, COVID-19 risk factors require further elucidation.
  • This study aimed to identify risk factors and clinical characteristics of COVID-19 in Jeddah, Saudi Arabia.

Purpose of the Study:

  • To characterize the risk factors associated with COVID-19.
  • To describe the clinical features of COVID-19 patients.
  • To investigate demographic and clinical data for COVID-19 in Jeddah.

Main Methods:

  • Retrospective, chart-review, case-control study design.
  • Inclusion of patients diagnosed between March 18 and May 18, 2020.
  • Analysis of demographic, clinical, radiological, and laboratory data.

Main Results:

  • 175 COVID-19 positive cases and 122 controls were analyzed.
  • Male gender, hypertension, and diabetes were more prevalent in COVID-19 patients.
  • Fever, cough, loss of taste/smell, and pneumonia were associated with positive COVID-19 diagnosis; lower lymphocyte and neutrophil counts observed.

Conclusions:

  • Male gender, hypertension, and diabetes are significant risk factors for COVID-19 in Jeddah.
  • COVID-19 patients exhibited significantly lower lymphocyte and neutrophil counts.
  • Understanding these factors aids in managing and preventing COVID-19 spread.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
234
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
179
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
369
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
105
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
166